APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex Concentrate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Prothrombin Complex Concentrate Industry Growth and Trends Forecast to 2032

22 December 2025113 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Concentrate Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Concentrate Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Concentrate Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Concentrate Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Human Prothrombin Complex Concentrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Prothrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Prothrombin Complex Concentrate include Takeda, Weiguang Biology, Thailand Bio, Shanghai Emerging Pharmaceuticals, Shanghai RAAS, Green Cross (China) Biological Products Co., Ltd., Jiangxi Boya Biopharmaceutical Co., Ltd., Hualan Bio and Guangdong Shuanglin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Prothrombin Complex Concentrate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Prothrombin Complex Concentrate market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Prothrombin Complex Concentrate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Prothrombin Complex Concentrate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Prothrombin Complex Concentrate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Prothrombin Complex Concentrate Market by Company

Takeda

Weiguang Biology

Thailand Bio

Shanghai Emerging Pharmaceuticals

Shanghai RAAS

Green Cross (China) Biological Products Co., Ltd.

Jiangxi Boya Biopharmaceutical Co., Ltd.

Hualan Bio

Guangdong Shuanglin Biopharmaceutical Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Beijing Bohui Innovative Biotechnology Group Co., Ltd.

Octapharma

Grifols

CSL

Biotest

Human Prothrombin Complex Concentrate Segment by Type

500 IU

1000 IU

Human Prothrombin Complex Concentrate Segment by Application

Hemophilia B

Vitamin K Deficiency

Other

Human Prothrombin Complex Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Prothrombin Complex Concentrate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Prothrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500 IU Table 2. Major Company of 1000 IU Table 3. Global Human Prothrombin Complex Concentrate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 5. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Prothrombin Complex Concentrate Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Prothrombin Complex Concentrate Sales by Type (2027-2032) & (k units) Table 10. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Prothrombin Complex Concentrate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Prothrombin Complex Concentrate Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 15. North America Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 17. Europe Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 21. Latin America Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Type (2021-2026) & (US$ Million) Table 24. Human Prothrombin Complex Concentrate Industry Trends Table 25. Human Prothrombin Complex Concentrate Industry Drivers Table 26. Human Prothrombin Complex Concentrate Industry Opportunities and Challenges Table 27. Human Prothrombin Complex Concentrate Industry Restraints Table 28. Global Human Prothrombin Complex Concentrate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Prothrombin Complex Concentrate Revenue Market Share by Company (2021-2026) Table 30. Global Human Prothrombin Complex Concentrate Sales by Company (2021-2026) & (k units) Table 31. Global Human Prothrombin Complex Concentrate Sales Share by Company (2021-2026) Table 32. Global Human Prothrombin Complex Concentrate Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Prothrombin Complex Concentrate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Prothrombin Complex Concentrate Major Company Production Sites and Headquarters Table 35. Global Human Prothrombin Complex Concentrate Company, Product Type & Application Table 36. Global Human Prothrombin Complex Concentrate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Prothrombin Complex Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Prothrombin Complex Concentrate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (k units) Table 41. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Prothrombin Complex Concentrate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Prothrombin Complex Concentrate Sales by Region (2027-2032) & (k units) Table 46. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Prothrombin Complex Concentrate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Prothrombin Complex Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Prothrombin Complex Concentrate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 52. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Prothrombin Complex Concentrate Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Prothrombin Complex Concentrate Sales by Application (2027-2032) & (k units) Table 57. Global Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Prothrombin Complex Concentrate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Prothrombin Complex Concentrate Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Prothrombin Complex Concentrate Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 62. North America Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 64. Europe Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 68. Latin America Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Human Prothrombin Complex Concentrate Product Portfolio Table 75. Takeda Recent Development Table 76. Weiguang Biology Company Information Table 77. Weiguang Biology Business Overview Table 78. Weiguang Biology Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio Table 80. Weiguang Biology Recent Development Table 81. Thailand Bio Company Information Table 82. Thailand Bio Business Overview Table 83. Thailand Bio Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio Table 85. Thailand Bio Recent Development Table 86. Shanghai Emerging Pharmaceuticals Company Information Table 87. Shanghai Emerging Pharmaceuticals Business Overview Table 88. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio Table 90. Shanghai Emerging Pharmaceuticals Recent Development Table 91. Shanghai RAAS Company Information Table 92. Shanghai RAAS Business Overview Table 93. Shanghai RAAS Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio Table 95. Shanghai RAAS Recent Development Table 96. Green Cross (China) Biological Products Co., Ltd. Company Information Table 97. Green Cross (China) Biological Products Co., Ltd. Business Overview Table 98. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 100. Green Cross (China) Biological Products Co., Ltd. Recent Development Table 101. Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information Table 102. Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview Table 103. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 105. Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Development Table 106. Hualan Bio Company Information Table 107. Hualan Bio Business Overview Table 108. Hualan Bio Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio Table 110. Hualan Bio Recent Development Table 111. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information Table 112. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview Table 113. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 115. Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Development Table 116. Beijing Tiantan Biological Products Co., Ltd. Company Information Table 117. Beijing Tiantan Biological Products Co., Ltd. Business Overview Table 118. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 120. Beijing Tiantan Biological Products Co., Ltd. Recent Development Table 121. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information Table 122. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview Table 123. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio Table 125. Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Development Table 126. Octapharma Company Information Table 127. Octapharma Business Overview Table 128. Octapharma Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Octapharma Human Prothrombin Complex Concentrate Product Portfolio Table 130. Octapharma Recent Development Table 131. Grifols Company Information Table 132. Grifols Business Overview Table 133. Grifols Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Grifols Human Prothrombin Complex Concentrate Product Portfolio Table 135. Grifols Recent Development Table 136. CSL Company Information Table 137. CSL Business Overview Table 138. CSL Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. CSL Human Prothrombin Complex Concentrate Product Portfolio Table 140. CSL Recent Development Table 141. Biotest Company Information Table 142. Biotest Business Overview Table 143. Biotest Human Prothrombin Complex Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Biotest Human Prothrombin Complex Concentrate Product Portfolio Table 145. Biotest Recent Development Table 146. North America Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 148. North America Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 149. North America Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Human Prothrombin Complex Concentrate Sales Market Share Forecast by Country (2027-2032) Table 151. North America Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Human Prothrombin Complex Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Human Prothrombin Complex Concentrate Market Share by Country (2021-2026) Table 154. North America Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Human Prothrombin Complex Concentrate Market Share Forecast by Country (2027-2032) Table 156. Europe Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 158. Europe Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 159. Europe Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Human Prothrombin Complex Concentrate Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Human Prothrombin Complex Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Human Prothrombin Complex Concentrate Market Share by Country (2021-2026) Table 164. Europe Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Human Prothrombin Complex Concentrate Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Human Prothrombin Complex Concentrate Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Human Prothrombin Complex Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Human Prothrombin Complex Concentrate Market Share by Country (2021-2026) Table 174. Asia-Pacific Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Human Prothrombin Complex Concentrate Market Share Forecast by Country (2027-2032) Table 176. Latin America Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 178. Latin America Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 179. Latin America Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Human Prothrombin Complex Concentrate Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Human Prothrombin Complex Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Human Prothrombin Complex Concentrate Market Share by Country (2021-2026) Table 184. Latin America Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Human Prothrombin Complex Concentrate Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Human Prothrombin Complex Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Human Prothrombin Complex Concentrate Market Share by Country (2021-2026) Table 194. Middle East and Africa Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Human Prothrombin Complex Concentrate Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Human Prothrombin Complex Concentrate Distributors List Table 199. Human Prothrombin Complex Concentrate Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Human Prothrombin Complex Concentrate Image Figure 2. Global Human Prothrombin Complex Concentrate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Prothrombin Complex Concentrate Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Prothrombin Complex Concentrate Sales (2021-2032) & (k units) Figure 5. 500 IU Image Figure 6. Global 500 IU Sales YoY Growth (2021-2032) & (k units) Figure 7. 1000 IU Image Figure 8. Global 1000 IU Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Human Prothrombin Complex Concentrate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Prothrombin Complex Concentrate Market Share by Type 2025 VS 2032 Figure 11. North America Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Prothrombin Complex Concentrate Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Prothrombin Complex Concentrate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Prothrombin Complex Concentrate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Prothrombin Complex Concentrate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Prothrombin Complex Concentrate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hemophilia B Image Figure 24. Global Hemophilia B Sales YoY Growth (2021-2032) & (k units) Figure 25. Vitamin K Deficiency Image Figure 26. Global Vitamin K Deficiency Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Human Prothrombin Complex Concentrate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Human Prothrombin Complex Concentrate Market Share by Application 2025 VS 2032 Figure 31. North America Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application in 2025 Figure 32. North America Human Prothrombin Complex Concentrate Sales Market Share in Value by Application in 2025 Figure 33. Europe Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application in 2025 Figure 34. Europe Human Prothrombin Complex Concentrate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Human Prothrombin Complex Concentrate Sales Market Share in Value by Application in 2025 Figure 37. Latin America Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Human Prothrombin Complex Concentrate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Human Prothrombin Complex Concentrate Sales Market Share in Value by Application in 2025 Figure 41. North America Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Human Prothrombin Complex Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Human Prothrombin Complex Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Human Prothrombin Complex Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Human Prothrombin Complex Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Human Prothrombin Complex Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Human Prothrombin Complex Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Human Prothrombin Complex Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Human Prothrombin Complex Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Human Prothrombin Complex Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Prothrombin Complex Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Human Prothrombin Complex Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Human Prothrombin Complex Concentrate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Human Prothrombin Complex Concentrate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU
  • 1000 IU
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Other
Companies covered
  • Takeda
  • Weiguang Biology
  • Thailand Bio
  • Shanghai Emerging Pharmaceuticals
  • Shanghai RAAS
  • Green Cross (China) Biological Products Co., Ltd.
  • Jiangxi Boya Biopharmaceutical Co., Ltd.
  • Hualan Bio
  • Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  • Octapharma
  • Grifols
  • CSL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Prothrombin Complex Concentrate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Prothrombin Complex Concentrate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Prothrombin Complex Concentrate Market by Type
  6. 1.3.1 500 IU
  7. 1.3.2 1000 IU
  8. 1.4 Global Human Prothrombin Complex Concentrate Market Size by Type
  9. 1.4.1 Global Human Prothrombin Complex Concentrate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Prothrombin Complex Concentrate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Prothrombin Complex Concentrate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Prothrombin Complex Concentrate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Prothrombin Complex Concentrate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Prothrombin Complex Concentrate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Prothrombin Complex Concentrate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Prothrombin Complex Concentrate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Prothrombin Complex Concentrate Industry Trends
  2. 2.2 Human Prothrombin Complex Concentrate Industry Drivers
  3. 2.3 Human Prothrombin Complex Concentrate Industry Opportunities and Challenges
  4. 2.4 Human Prothrombin Complex Concentrate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Prothrombin Complex Concentrate Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Prothrombin Complex Concentrate Sales (2021-2026)
  3. 3.3 Global Top Players by Human Prothrombin Complex Concentrate Price (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Concentrate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Prothrombin Complex Concentrate Major Company Production Sites & Headquarters
  6. 3.6 Global Human Prothrombin Complex Concentrate Company, Product Type & Application
  7. 3.7 Global Human Prothrombin Complex Concentrate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Prothrombin Complex Concentrate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Prothrombin Complex Concentrate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Prothrombin Complex Concentrate Tier 1, Tier 2, and Tier 3
4 Human Prothrombin Complex Concentrate Regional Status and Outlook
  1. 4.1 Global Human Prothrombin Complex Concentrate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Prothrombin Complex Concentrate Historic Market Size by Region
  3. 4.2.1 Global Human Prothrombin Complex Concentrate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Prothrombin Complex Concentrate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Prothrombin Complex Concentrate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Prothrombin Complex Concentrate Forecasted Market Size by Region
  7. 4.3.1 Global Human Prothrombin Complex Concentrate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Prothrombin Complex Concentrate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Prothrombin Complex Concentrate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Prothrombin Complex Concentrate by Application
  1. 5.1 Human Prothrombin Complex Concentrate Market by Application
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Other
  5. 5.2 Global Human Prothrombin Complex Concentrate Market Size by Application
  6. 5.2.1 Global Human Prothrombin Complex Concentrate Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Prothrombin Complex Concentrate Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Prothrombin Complex Concentrate Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Prothrombin Complex Concentrate Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Prothrombin Complex Concentrate Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Prothrombin Complex Concentrate Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Prothrombin Complex Concentrate Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Prothrombin Complex Concentrate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Human Prothrombin Complex Concentrate Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Weiguang Biology
  8. 6.2.1 Weiguang Biology Company Information
  9. 6.2.2 Weiguang Biology Business Overview
  10. 6.2.3 Weiguang Biology Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Weiguang Biology Human Prothrombin Complex Concentrate Product Portfolio
  12. 6.2.5 Weiguang Biology Recent Developments
  13. 6.3 Thailand Bio
  14. 6.3.1 Thailand Bio Company Information
  15. 6.3.2 Thailand Bio Business Overview
  16. 6.3.3 Thailand Bio Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Thailand Bio Human Prothrombin Complex Concentrate Product Portfolio
  18. 6.3.5 Thailand Bio Recent Developments
  19. 6.4 Shanghai Emerging Pharmaceuticals
  20. 6.4.1 Shanghai Emerging Pharmaceuticals Company Information
  21. 6.4.2 Shanghai Emerging Pharmaceuticals Business Overview
  22. 6.4.3 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Emerging Pharmaceuticals Human Prothrombin Complex Concentrate Product Portfolio
  24. 6.4.5 Shanghai Emerging Pharmaceuticals Recent Developments
  25. 6.5 Shanghai RAAS
  26. 6.5.1 Shanghai RAAS Company Information
  27. 6.5.2 Shanghai RAAS Business Overview
  28. 6.5.3 Shanghai RAAS Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai RAAS Human Prothrombin Complex Concentrate Product Portfolio
  30. 6.5.5 Shanghai RAAS Recent Developments
  31. 6.6 Green Cross (China) Biological Products Co., Ltd.
  32. 6.6.1 Green Cross (China) Biological Products Co., Ltd. Company Information
  33. 6.6.2 Green Cross (China) Biological Products Co., Ltd. Business Overview
  34. 6.6.3 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Green Cross (China) Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  36. 6.6.5 Green Cross (China) Biological Products Co., Ltd. Recent Developments
  37. 6.7 Jiangxi Boya Biopharmaceutical Co., Ltd.
  38. 6.7.1 Jiangxi Boya Biopharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Jiangxi Boya Biopharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangxi Boya Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  42. 6.7.5 Jiangxi Boya Biopharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Hualan Bio
  44. 6.8.1 Hualan Bio Company Information
  45. 6.8.2 Hualan Bio Business Overview
  46. 6.8.3 Hualan Bio Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hualan Bio Human Prothrombin Complex Concentrate Product Portfolio
  48. 6.8.5 Hualan Bio Recent Developments
  49. 6.9 Guangdong Shuanglin Biopharmaceutical Co., Ltd.
  50. 6.9.1 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  54. 6.9.5 Guangdong Shuanglin Biopharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Beijing Tiantan Biological Products Co., Ltd.
  56. 6.10.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  57. 6.10.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
  58. 6.10.3 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Beijing Tiantan Biological Products Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  60. 6.10.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
  61. 6.11 Beijing Bohui Innovative Biotechnology Group Co., Ltd.
  62. 6.11.1 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Company Information
  63. 6.11.2 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Business Overview
  64. 6.11.3 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Human Prothrombin Complex Concentrate Product Portfolio
  66. 6.11.5 Beijing Bohui Innovative Biotechnology Group Co., Ltd. Recent Developments
  67. 6.12 Octapharma
  68. 6.12.1 Octapharma Company Information
  69. 6.12.2 Octapharma Business Overview
  70. 6.12.3 Octapharma Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Octapharma Human Prothrombin Complex Concentrate Product Portfolio
  72. 6.12.5 Octapharma Recent Developments
  73. 6.13 Grifols
  74. 6.13.1 Grifols Company Information
  75. 6.13.2 Grifols Business Overview
  76. 6.13.3 Grifols Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Grifols Human Prothrombin Complex Concentrate Product Portfolio
  78. 6.13.5 Grifols Recent Developments
  79. 6.14 CSL
  80. 6.14.1 CSL Company Information
  81. 6.14.2 CSL Business Overview
  82. 6.14.3 CSL Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CSL Human Prothrombin Complex Concentrate Product Portfolio
  84. 6.14.5 CSL Recent Developments
  85. 6.15 Biotest
  86. 6.15.1 Biotest Company Information
  87. 6.15.2 Biotest Business Overview
  88. 6.15.3 Biotest Human Prothrombin Complex Concentrate Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Biotest Human Prothrombin Complex Concentrate Product Portfolio
  90. 6.15.5 Biotest Recent Developments
7 North America by Country
  1. 7.1 North America Human Prothrombin Complex Concentrate Sales by Country
  2. 7.1.1 North America Human Prothrombin Complex Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
  4. 7.1.3 North America Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Prothrombin Complex Concentrate Market Size by Country
  6. 7.2.1 North America Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Prothrombin Complex Concentrate Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Prothrombin Complex Concentrate Sales by Country
  2. 8.1.1 Europe Human Prothrombin Complex Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Prothrombin Complex Concentrate Market Size by Country
  6. 8.2.1 Europe Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Prothrombin Complex Concentrate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales by Country
  2. 9.1.1 Asia-Pacific Human Prothrombin Complex Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Prothrombin Complex Concentrate Market Size by Country
  6. 9.2.1 Asia-Pacific Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Prothrombin Complex Concentrate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Prothrombin Complex Concentrate Sales by Country
  2. 10.1.1 South America Human Prothrombin Complex Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
  4. 10.1.3 South America Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Prothrombin Complex Concentrate Market Size by Country
  6. 10.2.1 South America Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Prothrombin Complex Concentrate Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country
  2. 11.1.1 Middle East and Africa Human Prothrombin Complex Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Prothrombin Complex Concentrate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Prothrombin Complex Concentrate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Prothrombin Complex Concentrate Market Size by Country
  6. 11.2.1 Middle East and Africa Human Prothrombin Complex Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Prothrombin Complex Concentrate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Prothrombin Complex Concentrate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Prothrombin Complex Concentrate Value Chain Analysis
  2. 12.1.1 Human Prothrombin Complex Concentrate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Prothrombin Complex Concentrate Production Mode & Process
  7. 12.2 Human Prothrombin Complex Concentrate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Prothrombin Complex Concentrate Distributors
  10. 12.2.3 Human Prothrombin Complex Concentrate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst